CLMTCalumet, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +62% vs its 200-day average.
No notable insider trading in the 90 days ending Oct 9, 2026.
Moderately shorted, settled Sep 30, 2026, a few days of normal trading to cover. Down 20% since the previous count, down from 4.9% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CLMT is trading
Calumet, Inc. is +205% over the past year while the S&P 500 is +18%: 187 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +62%
vs 200-day average · a clear uptrend
- RSI (14)
- 44
RSI (14) · neutral
- Below its 52-week high
- 4.4%
Below its 52-week high
Details›
- Last close2026-10-09
- $56.42
- 1 monthS&P 500 +2.7%
- −0.12%
- 1 yearS&P 500 +18%
- +205%
- 5 yearsS&P 500 +88%
- +683%
- vs 50-day average$51.19
- +10%
- 52-week high
- $59.03
- 52-week low
- $17.68
- Annualised volatility
- 56%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-09
- −$21M
| Year | Return |
|---|---|
| 2026 (year to date) | +184% |
| 2025 | −9.8% |
| 2024 | +23% |
| 2023 | +5.9% |
| 2022 | +28% |
| 2021 | +322% |
| 2020 | −14% |
| 2019 | +65% |
| 2018 | −71% |
| 2017 | +92% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +4.0% |
| Feb | 10 | 5 of 10 | +1.2% |
| Mar | 10 | 4 of 10 | +0.99% |
| Apr | 10 | 4 of 10 | +6.1% |
| May | 10 | 8 of 10 | +11% |
| Jun | 10 | 4 of 10 | −1.2% |
| Jul | 11 | 8 of 11 | +6.1% |
| Aug | 11 | 8 of 11 | +14% |
| Sep | 11 | 5 of 11 | −1.6% |
| Oct | 11 | 7 of 11 | +7.9% |
| Nov | 10 | 5 of 10 | +1.9% |
| Dec | 10 | 4 of 10 | −3.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Specialty Chemicals
Ranks #31 of 33 by RyuScore